Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Glycine and a glycine dehydrogenase (GLDC) SNP as citalopram/escitalopram response biomarkers in depression: pharmacometabolomics-informed pharmacogenomics.

Ji Y, Hebbring S, Zhu H, Jenkins GD, Biernacka J, Snyder K, Drews M, Fiehn O, Zeng Z, Schaid D, Mrazek DA, Kaddurah-Daouk R, Weinshilboum RM.

Clin Pharmacol Ther. 2011 Jan;89(1):97-104. doi: 10.1038/clpt.2010.250. Epub 2010 Nov 24.

2.
3.

Escitalopram: a review of its use in the management of major depressive disorder in adults.

Garnock-Jones KP, McCormack PL.

CNS Drugs. 2010 Sep;24(9):769-96. doi: 10.2165/11204760-000000000-00000. Review.

PMID:
20806989
4.

[Escitalopram for treatment of major depressive disorder in adults].

Llorca PM, Brousse G, Schwan R.

Encephale. 2005 Jul-Aug;31(4 Pt 1):490-501. Review. French.

PMID:
16389716
5.

Escitalopram (Lexapro) for depression.

Masilamani S, Ruppelt SC.

Am Fam Physician. 2003 Dec 1;68(11):2235-6. Review.

6.

Clinical pharmacology review of escitalopram for the treatment of depression.

Pastoor D, Gobburu J.

Expert Opin Drug Metab Toxicol. 2014 Jan;10(1):121-8. doi: 10.1517/17425255.2014.863873. Epub 2013 Nov 30. Review.

PMID:
24289655
7.

Spotlight on the pharmacoeconomics of escitalopram in depression.

Croom KF, Plosker GL.

CNS Drugs. 2004;18(7):469-73. Review.

PMID:
15139801
9.

Escitalopram: a review of its use in the management of major depressive disorder.

Murdoch D, Keam SJ.

Drugs. 2005;65(16):2379-404. Review.

PMID:
16266205
10.

A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?

Sanchez C, Reines EH, Montgomery SA.

Int Clin Psychopharmacol. 2014 Jul;29(4):185-96. doi: 10.1097/YIC.0000000000000023. Review.

11.

Pharmacometabolomics: implications for clinical pharmacology and systems pharmacology.

Kaddurah-Daouk R, Weinshilboum RM; Pharmacometabolomics Research Network.

Clin Pharmacol Ther. 2014 Feb;95(2):154-67. doi: 10.1038/clpt.2013.217. Epub 2013 Nov 5. Review.

PMID:
24193171
12.

Metabolomic Signatures for Drug Response Phenotypes: Pharmacometabolomics Enables Precision Medicine.

Kaddurah-Daouk R, Weinshilboum R; Pharmacometabolomics Research Network.

Clin Pharmacol Ther. 2015 Jul;98(1):71-5. doi: 10.1002/cpt.134. Epub 2015 Jun 4. Review.

13.

The Implications of Metabotypes for Rationalizing Therapeutics in Infants and Children.

Katsila T, Patrinos GP.

Front Pediatr. 2015 Jul 29;3:68. doi: 10.3389/fped.2015.00068. eCollection 2015. Review. No abstract available.

Supplemental Content

Support Center